Insmed (INSM)

Add to Watchlists Create an Alert
17.22 +0.13  +0.76% NASDAQ Aug 1, 4:59PM BATS Real time Currency in USD
View Full Chart
INSM Price Chart
View All Events

INSM Events

Date Type Description
05/29/2014 Misc Annual General Meeting for Insmed Inc
05/08/2014 Earnings Insmed Inc 1Q2014 Earning Result. Estimate: -0.39.
03/06/2014 Earnings Insmed, Inc. Q4 2013 Earnings Results. Estimate: -0.40.
11/05/2013 08:30 EDT Misc Insmed to Host Third Quarter 2013 Financial Results Conference Call
11/05/2013 Earnings Insmed to Host Third Quarter 2013 Financial Results. Estimate: -0.34.
08/06/2013 08:30 EDT Misc Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013
08/06/2013 Earnings Insmed Announces Second Quarter 2013 Financial Results. Estimate: -0.42.
View All Performance Charts

INSM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Insmed is up 55.70% over the last year vs S&P 500 Total Return up 16.61%, Achillion Pharmaceuticals down 1.26%, and OxiGene down 10.71%.

Get Quote for
Advertisement

Portfolio Strategies Featuring INSM

Did Insmed make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

INSM Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.insmed.com
  • IR Website: http://investor.insmed.com/index.cfm
  • HQ Country: United States
  • HQ State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Virginia
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Insmed, Inc. is a biopharmaceutical company engaged in developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. Its lead product candidate is ARIKAYCE.

INSM Excel Add-In Codes

  • Name: =YCI("INSM","name")
  • Description: =YCI("INSM","description")
  • Sector: =YCI("INSM","sector")
  • Industry: =YCI("INSM","industry")
  • Est. Current Fiscal Year End: =YCI("INSM","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.